This article was originally published in Start Up
Executive SummaryProteomTech Inc. has developed a protocol for speeding up the protein refolding process so it can be completed in 24-to-48 hours. It's strategy for generating revenues includes contract manufacturing for the research market, a service business that may one day grow to include manufacture of protein drugs
You may also be interested in...
BMS’ strategy for the complex, highly competitive immuno-oncology field. A Q&A with the company’s new R&D chief, lung cancer specialist Thomas Lynch, MD.